Cite
HARVARD Citation
Li, X. et al. (2022). A Case of Daratumumab-Induced Significant Decrease in Donor-Specific HLA Antibodies and Remission Induction Before Haploidentical Stem Cell Transplantation in a Refractory B-ALL Patient. Cell transplantation. p. . [Online].